文献リスト

1）Kay EB, Suzuki A, Mendelsohn D Jr. Operative results in aortic valve surgery. Circulation. 1962; 26: 484-93

2）Bristow JD, Mccord CW, Starr A, et al. Clinical and hemodynamic results of aortic valvular replacement with a ball-valve prosthesis. Circulation. 1964; 29 Suppl: 36-46

3）Orszulak TA, Schaff HV, Puga FJ, et al. Event status of the Starr-Edwards aortic valve to 20 years: a benchmark for comparison. Ann Thorac Surg. 1997; 63: 620-6

4）Osnabrugge RL, Mylotte D, Head SJ, et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013; 62: 1002-12

5）Amano J, Kuwano H, Yokomise H. Thoracic and cardiovascular surgery in Japan during 2011: Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2013; 61: 578-607

6）厚生労働省ホームページ　平成25年簡易生命表の概況. available at http://www.mhlw.go.jp/toukei/saikin/hw/life/life13/dl/life13-14.pdf

7）Brennan JM, Edwards FH, Zhao Y, et al. Long-term survival after aortic valve replacement among high-risk elderly patients in the United States: insights from the Society of Thoracic Surgeons Adult Cardiac Surgery Database, 1991 to 2007. Circulation. 2012; 126: 1621-9

8）Nakano K, Koyanagi H, Hashimoto A, et al. Twelve years’ experience with the St. Jude Medical valve prosthesis. Ann Thorac Surg. 1994; 57: 697-702

9）Aoyagi S, Oryoji A, Nishi Y, et al. Long-term results of valve replacement with the St. Jude Medical valve. J Thorac Cardiovasc Surg. 1994; 108: 1021-9

10）Taniguchi S, Hashizume K, Ariyoshi T, et al. Twelve years of experience with the ATS mechanical heart valve prostheses. Gen Thorac Cardiovasc Surg. 2012; 60: 561-8

11）Teshima H, Hayashida N, Yano H, et al. Obstruction of St Jude Medical valves in the aortic position: histology and immunohistochemistry of pannus. J Thorac Cardiovasc Surg. 2003; 126: 401-7

12）Petersen P, Grind M, Adler J, et al. SPORTIF II: a dose-guiding, tolerability, and safety study. J Am Coll Cardiol. 2003; 41: 1445-51

13）Poli D, Antonucci E, Grifoni E, et al. Bleeding risk during oral anticoagulation in atrial fibrillation patients older than 80 years. J Am Coll Cardiol. 2009; 54: 999-1002

14）Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial. Lancet. 1996; 348: 633-8

15）Aziz F, Corder M, Wolffe J, et al. Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care. J Vasc Surg. 2011; 54: 1404-7

16）Menéndez-Jándula B, Souto JC, Oliver A, et al. Comparing self-management of oral anticoagulant therapy with clinic management: a randomized trial. Ann Intern Med. 2005; 142: 1-10

17）Eikelboom JW, Connolly SJ, Brueckmann M, et al. Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med. 2013; 369: 1206-14

18）David TE, Armstrong S, Maganti M. Hancock II. Bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability? Ann Thorac Surg. 2010; 90: 775-81

19）Jamieson WR, Riess FC, Raudkivi PJ, et al. Medtronic Mosaic porcine bioprosthesis: assessment of 12-year performance. J Thorac Cardiovasc Surg. 2011; 142: 302-7

20）McClure RS, Narayanasamy N, Wiegerinck E, et al. Late outcomes for aortic valve replacement with the Carpentier-Edwards pericardial bioprosthesis: up to 17-year follow-up in 1,000 patients. Ann Thorac Surg. 2010; 89: 1410-6

21）Banbury MK, Cosgrove DM 3rd, White JA, et al. Age and valve size effect on the long-term durability of the Carpentier-Edwards aortic pericardial bioprosthesis. Ann Thorac Surg. 2001; 72: 753-7

22）Forcillo J, Pellerin M, Perrault LP, et al. Carpentier-Edwards pericardial valve in the aortic position: 25-years experience. Ann Thorac Surg. 2013; 96: 486-93

23）Aupart MR, Mirza A, Meurisse YA, et al. Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients. J Heart Valve Dis. 2006; 15: 768-75

24）Minakata K, Tanaka S, Okawa Y, et al. Long-term outcomes of the carpentier -edwards pericardial valve in the aortic position in Japanese patients. Circ J. 2014: 78; 882-9

25）Hammermeister KE, Sethi GK, Henderson WC, et al. Outcomes 15 years after valve replacement with a mechanical versus bioprosthetic valve: final report of the Veterans affairs randomized trial. J Am Coll Cardiol. 2000; 36: 1152-8

26）Bloomfield P, Wheatley DJ, Prescott RJ, et al. Twelve-year comparison of a Bjork-Shiley mechanical heart-valve with porcine bioprosthesis. N Engl J Med. 1991; 324: 573-9

27）Oxenham H, Bloomfield P, Wheatley DJ, et al.Twenty year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart. 2003; 89: 715-21

28）Stassano P, Di Tommaso L, Monaco M, et al. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years. J Am Coll Cardiol. 2009; 54: 1862-8

29）Suri RM, Schaff HV. Selection of aortic valve prostheses: contemporary reappraisal of mechanical versus biologic valve substitutes. Circulation. 2013; 128: 1372-80

30）Brown ML, Schaff HV, Lahr BD, et al. Aortic valve replacement in patients aged 50 to 70 years: improved outcome with mechanical versus biologic prostheses. J Thorac Cardiovasc Surg. 2008; 135: 878-84

31）Kaneko T, Cohn LH, Aranki SF. Tissue valve is the preferred option for patients aged 60 and older. Circulation. 2013; 128: 1365-71

32）Potter DD, Sundt TM 3rd, Zehr KJ, et al. Operative risk of reoperative aortic valve replacement. J Thorac Cardiovasc Surg. 2005; 129: 94-103

33）American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons; Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation. 2006; 114: e84-231

34）Okita Y, Okada Y, Otsuji Y, et al. Guidelines for Surgical and Interventional Treatment of Valvular Heart Disease. Japanese Circulation Society, 2012. Available at http://www.j-circ.or.jp/guideline/pdf/JCS2012_ookita_h.pdf (Last accessed: August 21, 2013)

35）Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012; 42: S1-44

36）January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Scociety. J Am Coll Cardiol. 2014; 64: 2246-80

37）Leon MB, Smith CR, Mack M, et al. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010; 363: 1597-607

38）Smith CR, Leon MB, Mack MJ, et al; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011; 364: 2187-98

39）Kodali SK, Williams MR, Smith CR, et al; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012; 366: 1686-95

40）Adams DH, Popma JJ, Reardon MJ, et al; U.S. CoreValve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014; 370: 1790-8

41）Ozaki S, Kawase I, Yamashita H, et al. A total of 404 cases of aortic valve reconstruction with glutaraldehyde-treated autologous pericardium. J Thorac Cardiovasc Surg. 2014; 147: 301-6

42）Dvir D, Webb JG, Bleiziffer S, et al. Valve-in-Valve International Data Registry Investigators. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. JAMA. 2014; 312: 162-70

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp